| Literature DB >> 35538052 |
David Willinger1,2, Iliana I Karipidis1,2,3, Isabelle Häberling1, Gregor Berger1, Susanne Walitza1,2, Silvia Brem4,5.
Abstract
Adolescence represents a critical developmental period where the prevalence of major depressive disorder (MDD) increases. Aberrant emotion processing is a core feature of adolescent MDD that has been associated with functional alterations within the prefrontal-amygdala circuitry. In this study, we tested cognitive and neural mechanisms of emotional face processing in adolescents with MDD utilizing a combination of computational modeling and neuroimaging. Thirty adolescents with MDD (age: M = 16.1 SD = 1.4, 20 females) and 33 healthy controls (age: M = 16.2 SD = 1.9, 20 females) performed a dynamic face- and shape-matching task. A linear ballistic accumulator model was fit to the behavioral data to study differences in evidence accumulation. We used dynamic causal modeling (DCM) to study effective connectivity in the prefrontal-amygdala network to reveal the neural underpinnings of cognitive impairments while performing the task. Face processing efficiency was reduced in the MDD group and most pronounced for ambiguous faces with neutral emotional expressions. Critically, this reduction was related to increased deactivation of the subgenual anterior cingulate (sgACC). Connectivity analysis showed that MDD exhibited altered functional coupling in a distributed network spanning the fusiform face area-lateral prefrontal cortex-sgACC and the sgACC-amygdala pathway. Our results suggest that MDD is related to impairments of processing nuanced facial expressions. Distributed dysfunctional coupling in the face processing network might result in inefficient evidence sampling and inappropriate emotional responses contributing to depressive symptomatology. Our study provides novel insights in the characterization of brain function in adolescents with MDD that strongly emphasize the critical role of aberrant prefrontal-amygdala interactions during emotional face processing.Entities:
Mesh:
Year: 2022 PMID: 35538052 PMCID: PMC9090758 DOI: 10.1038/s41398-022-01955-5
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 7.989
Clinical and demographic characteristics of study participants.
| Controls | MDD | Test statistic | ||
|---|---|---|---|---|
| Age (years), range (min-max) | 16.2 (1.9), 11.2–18.8 | 16.1 (1.4), 12.8–18.7 | U = 553.5 | 0.425 |
| Sex (males), No. (%) | 10 (30%) | 10 (33%) | χ2(1) = 0.07 | 0.796 |
| Handedness (right), No. (%) | 32 (97%) | 28 (93%) | χ2(1) = 0.46 | 0.500 |
| In-scanner movement (FD, mm) | 0.16 (0.06) | 0.17 (0.06) | t(61) = 0.69 | 0.492 |
| CD-RISC | 72.9 (10.1) | 38.6 (15.6) | t(58) = 10.16 | <0.001 |
| CDI | 8.4 (6.6) | 29.6 (9.3) | U = 38.0 | <0.001 |
| Anhedonia | 2.3 (2.2) | 10.5 (2.8) | U = 13.5 | <0.001 |
| Negative mood | 2.2 (2.0) | 6.4 (2.4) | U = 88.0 | <0.001 |
| Negative self-esteem | 1.0 (1.2) | 5.0 (1.7) | U = 42.0 | <0.001 |
| Ineffectiveness | 1.2 (1.2) | 5.0 (1.9) | U = 54.5 | <0.001 |
| Interpersonal problems | 1.1 (1.2) | 3.7 (1.5) | U = 74.5 | <0.001 |
| Stomach | 0.6 (0.6) | 1.1 (0.8) | U = 301.5 | 0.018 |
| RIAS IQ | 104.5 (6.9) | 108.0 (8.7) | t(60) = −1.75 | 0.079 |
| PSS | 22.4 (6.6) | 28.8 (7.7) | t(57) = −3.44 | 0.001 |
| SDQ | 8.8 (5.3) | 16.3 (5.6) | t(56) = −5.26 | <0.001 |
| WISC-IV Digitspan (forward) | 8.9 (2.1) | 8.8 (2.0) | t(60) = 0.32 | 0.747 |
| WISC-IV Digitspan (backward) | 8.6 (1.6) | 9.4 (2.0) | t(60) = −1.70 | 0.094 |
| WISC-IV Mosaic | 57.0 (5.7) | 59.0 (6.2) | t(56) = −1.27 | 0.208 |
| Current Medication, No. (%) | ||||
| No medication | 33 (100%) | 10 (33%) | NA | NA |
| SSRI | 0 | 18 (60%) | NA | NA |
| Dual-action antidepressantb | 0 | 2 (7%) | NA | NA |
| NERI | 0 | 2 (7%) | NA | NA |
| Antipsychoticc | 0 | 2 (7%) | NA | NA |
| Methylphenidate | 0 | 2 (7%) | NA | NA |
Data are presented as mean (SD) if not indicated otherwise.
CD-RISC Connor-Davidson Resilience Scale, CDI Children Depression Inventory, FD framewise displacement, NERI Norepinephrine reuptake inhibitor, PSS Perceived Stress Scale, RIAS Reynolds Intellectual Assessment Scales, SDQ Strength and Difficulty Questionnaire for Children, SSRI Selective serotonin reuptake inhibitor, WISC Wechsler Intelligence Scale for Children.
aUncorrected p values for between-group comparisons; significance threshold p < 0.05.
bSerotonin-noradrenalin reuptake inhibitor.
cUsed for behavioral control.
Fig. 1Behavioral parameters.
Patients exhibited slower information processing efficiency represented by the lower drift rate during the face matching of neutral faces (Table S4).
Fig. 2Analysis pipeline.
The analysis harnessed generative models of participants’ behavior and neural dynamics. The decision components for the face matching task (e.g. drift rate) were used to identify a network of brain regions from which we were able to derive a mechanistic understanding of behavioral differences. These regions were then used to establish a DCM that describes functional coupling within the network circuitry. Statistical inference was performed separately on LBA and DCM parameters.
Fig. 3Whole-brain activity analysis.
A Brain activity for the task (faces-shapes) across both groups. We found activity in the amygdala, the fusiform gyrus, the ventromedial prefrontal cortex (vmPFC), ventrolateral prefrontal cortex (vlPFC), and in a cluster comprising the superior temporal sulcus (STS) and the temporo-parietal junction (TPJ). B Brain activity positively associated with the drift rate (i.e. information processing efficiency) during the neutrally/ambiguous valenced dynamic face matching. We found that a slower drift rate is related to a cluster in the subgenual anterior cingulate cortex (sgACC). pFWEc < 0.05, pCDT < 0.001, N = 63.
Fig. 4DCM analysis of the prefrontal-amygdala network.
A The common effect represents the overall model structure for the baseline (neutral faces) across all participants. B Group differences were primarily found in the bidirectional cortical pathway FFA-LPFC-sgACC for the average connectivity across conditions. In addition, connectivity between sgACC and the amygdala was decreased in patients. C, D Efferent connectivity from the amygdala was modulated by positive (C) and negative (D) valence. In addition, processing of positive valence was associated with altered LPFC—amygdala connectivity and the LPFC—sgACC—amygdala pathway. Detailed results are reported in Table S7. AMY amygdala, FFA fusiform face area, HC healthy controls, LPFC lateral prefrontal cortex, MDD major depressive disorder, sgACC subgenual anterior cingulate cortex.